CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-10-15 | Havey Adam EVP, Business Operations | Sale | −6,165 | $60.15 | $371K | 29,914 |
| 2018-10-15 | Havey Adam EVP, Business Operations | Exercise or conversion | +6,165 | $25.62 | $158K | 36,079 |
| 2018-10-15 | Havey Adam EVP, Business Operations | Sale | −6,165 | $60.03 | $370K | 29,914 |
| 2018-10-15 | Havey Adam EVP, Business Operations | Sale | −661 | $60.67 | $40K | 29,253 |
| 2018-10-15 | Havey Adam EVP, Business Operations | Exercise or conversion · Stock Option (Right to Buy) | −6,165 | 24,663 | ||
| 2018-10-15 | Havey Adam EVP, Business Operations | Exercise or conversion · Stock Option (Right to Buy) | −6,165 | 18,498 | ||
| 2018-09-17 | Abdun-Nabi Daniel CEO | Exercise or conversion | +1,319 | $13.38 | $18K | 167,886 |
| 2018-09-17 | Abdun-Nabi Daniel CEO | Sale | −1,319 | $65.00 | $86K | 166,567 |
| 2018-09-17 | Abdun-Nabi Daniel CEO | Exercise or conversion · Stock Option (Right to Buy) | +1,319 | 0 | ||
| 2018-09-14 | Abdun-Nabi Daniel CEO | Exercise or conversion | +28,220 | $13.38 | $378K | 194,787 |
| 2018-09-14 | Abdun-Nabi Daniel CEO | Sale | −28,220 | $65.00 | $1.8M | 166,567 |
| 2018-09-14 | Abdun-Nabi Daniel CEO | Exercise or conversion · Stock Option (Right to Buy) | +28,220 | 1,319 | ||
| 2018-09-05 | Abdun-Nabi Daniel CEO | Sale | −30,776 | $59.49 | $1.8M | 166,567 |
| 2018-09-04 | Abdun-Nabi Daniel CEO | Exercise or conversion | +60,000 | $13.38 | $803K | 257,343 |
| 2018-09-04 | Abdun-Nabi Daniel CEO | Sale | −60,000 | $60.54 | $3.6M | 197,343 |
| 2018-09-04 | Abdun-Nabi Daniel CEO | Exercise or conversion · Stock Option (Right to Buy) | −60,000 | 29,539 | ||
| 2018-08-21 | Richard Ronald Director | Exercise or conversion | +7,793 | $14.71 | $115K | 28,756 |
| 2018-08-21 | Richard Ronald Director | Sale | −7,793 | $60.02 | $468K | 20,963 |
| 2018-08-21 | Richard Ronald Director | Exercise or conversion · Stock Option (Right to Bury) | −7,793 | $14.71 | $115K | 0 |
| 2018-08-14 | El-Hibri Fuad Chairman | Sale | −16,318 | $56.57 | $923K | 1,488,675 |
Page 37 of 45 · 887 trades